login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Codman Neurovascular launches two new microcoil systems, new distal access catheter at SNIS


Thursday, 16 Aug 2012 10:20
Deltamaxx
Deltamaxx


Codman Neurovascular has announced the launch of the Deltamaxx Microcoil System, and Orbit Galaxy G2 Microcoils, which for the first time puts Orbit Galaxy coils on the EnpowerDetachment System, developed by Micrus Endovascular. Both new microcoil systems are now available in the United States and Europe. 


The announcement was made at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting where Codman Neurovascular featured the two new microcoil systems alongside the Envoy DA, a new distal access guiding catheter that facilitates navigation through tortuous portions of the carotid siphon and provides the stability required for complex neurointerventional procedures.


The DeltamaxxMicrocoil System features Codman’s Deltawindtechnology, a unique triangular wind shape with natural deflection points that enables the coil to change direction more easily than traditional circular wind coils. This is the longest microcoil the company has ever introduced, with lengths of up to 60cm. The coil is compatible with microcatheters with inner lumen diameters ranging from 0.0165” to 0.019”, such as Codman’s Prowlercatheters, which can also accommodate smaller finishing coils.


Codman Neurovascular also introduced Orbit Galaxy G2 Microcoils, a system of complex shaped, soft and highly conformable coils with random break points that has been shown to deliver high packing densities and result in low re-treatment rates. These new coils are deployed with the EnpowerDetachment System, a push-button thermomechanical detachment that streamlines the coiling procedure.


Finally, the company introduced the new Envoy DA Guiding Catheter, its first distal access guiding catheter, which features a braid design, soft distal tip, and hydrophilic coating and larger inner lumen.




Add New Comment

Related Items


Most popular


Better outcomes observed in MR CLEAN non-general anaesthesia subgroup in post-hoc analysis
Thursday, 02 Apr 2015
In a post-hoc analysis of the use of general anaesthesia in the MR CLEAN trial (Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands) ... Better outcomes observed in MR CLEAN non-general anaesthesia subgroup in post-hoc analysis

Study suggests feasibility of Baby Trevo for treatment of distal cerebrovascular occlusions
Thursday, 14 May 2015
Diogo Haussen and colleagues (Emory University School of Medicine, Atlanta, USA) report that their initial data suggest that treatment of distal cerebrovascular occlusions with the Trevo XP ProVue 3x2... Study suggests feasibility of Baby Trevo for treatment of distal cerebrovascular occlusions

Evidence builds for endovascular treatment of acute ischaemic stroke
Friday, 17 Apr 2015
With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT ... Evidence builds for endovascular treatment of acute ischaemic stroke

Features


New day in acute ischaemic stroke therapy
Friday, 17 Apr 2015
The newest generation of trials for acute ischaemic stroke, including MR CLEAN, ESCAPE, EXTEND IA and SWIFT PRIME, appear to have ushered in a new era in stroke therapy. Now, Joseph Broderick (... New day in acute ischaemic stroke therapy

Flow diverter technology for intracranial aneurysms
Tuesday, 31 Mar 2015
Gabor Toth writes for NeuroNews about the flow diverters that are currently available and the ongoing clinical trials that could have the potential to extend the indications of flow diverter therapy ... Flow diverter technology for intracranial aneurysms

Profiles


Robert E Harbaugh
Thursday, 14 May 2015
Robert E Harbaugh speaks to NeuroNews about how far neurosurgery has come, and as president of AANS ... Robert E Harbaugh

Joseph Broderick
Wednesday, 07 Jan 2015
Joseph Broderick speaks to NeuroNews about the future of neurology and his research, in particular, ... Joseph Broderick

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions